ATP1AL1, a crucial component of the non-gastric H,K-ATPase family, plays a vital role in maintaining cellular ion homeostasis through its sodium pump function. Unlike its gastric counterparts that primarily facilitate acid secretion in the stomach, ATP1AL1 is expressed in various tissues, including the kidney and colon, where it actively participates in the regulation of sodium and potassium ion gradients across the cell membrane. This enzymatic pump operates by exchanging sodium ions from the intracellular space for potassium ions from the extracellular space, a process essential for numerous physiological functions such as nerve impulse transmission, muscle contraction, and the maintenance of cellular volume and pH balance. The activity of ATP1AL1 is thus fundamental not only for the individual cell's homeostasis but also plays a significant role in the overall electrolyte balance and blood pressure regulation within the body.
The activation of ATP1AL1, similar to other members of the P-type ATPase family, is intricately linked to the phosphorylation state of the protein, which is governed by the availability of ATP and the intracellular concentrations of sodium and potassium ions. The pump cycle involves the autophosphorylation of the ATPase at a conserved aspartate residue, a step that is triggered by the binding of intracellular sodium ions. This phosphorylation induces a conformational change in the protein, facilitating the release of sodium ions to the extracellular space. Subsequent binding of extracellular potassium ions leads to the dephosphorylation of the ATPase, returning the protein to its original conformation and allowing the transport of potassium ions into the cell. This cycle is critically dependent on the presence of ATP, which provides the energy required for the conformational changes and phosphorylation/dephosphorylation events. Moreover, the activity of ATP1AL1 is also modulated by the lipid composition of the cell membrane, with certain phospholipids known to influence its stability and function. The precise regulation of ATP1AL1's activity is therefore a complex interplay between its phosphorylation state, ATP availability, ion gradients, and membrane lipid environment, ensuring the efficient and timely response to the changing needs of the cell and organism.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Dopamine | 51-61-6 | sc-507336 | 1 g | $290.00 | ||
A neurotransmitter that can affect Na+/K+ ATPase activity, which may in turn influence ATP1AL1. | ||||||
Aldosterone | 52-39-1 | sc-210774 sc-210774A sc-210774B sc-210774C sc-210774D sc-210774E | 2 mg 5 mg 10 mg 50 mg 100 mg 250 mg | $259.00 $213.00 $317.00 $1550.00 $3074.00 $7637.00 | 1 | |
A steroid hormone that regulates Na+/K+ ATPase expression, potentially affecting ATP1AL1 activity. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Known to modulate Na+/K+ ATPase activity, insulin could indirectly influence ATP1AL1. | ||||||
L-3,3′,5-Triiodothyronine, Sodium Salt | 55-06-1 | sc-205725 | 250 mg | $115.00 | ||
Triiodothyronine (T3) can regulate Na+/K+ ATPase activity, potentially affecting ATP1AL1. | ||||||
Adenosine 3′,5′-cyclic monophosphate | 60-92-4 | sc-217584 sc-217584A sc-217584B sc-217584C sc-217584D sc-217584E | 100 mg 250 mg 5 g 10 g 25 g 50 g | $116.00 $179.00 $265.00 $369.00 $629.00 $1150.00 | ||
As a secondary messenger, cAMP can modulate Na+/K+ ATPase activity, potentially impacting ATP1AL1. | ||||||
Angiotensin II, Human | 4474-91-3 | sc-363643 sc-363643A sc-363643B sc-363643C | 1 mg 5 mg 25 mg 100 mg | $51.00 $100.00 $310.00 $690.00 | 3 | |
A peptide hormone that can regulate Na+/K+ ATPase activity, potentially affecting ATP1AL1 indirectly. | ||||||
Calcium | 7440-70-2 | sc-252536 | 5 g | $209.00 | ||
Intracellular calcium levels can influence Na+/K+ ATPase activity, potentially impacting ATP1AL1. | ||||||